LBA Nordic Study: Low-Dose Aspirin Reduces Recurrence in Colorectal Cancer Patients with PI3K Pathway Mutations
Low-dose aspirin shows potential as a targeted, cost-effective treatment option to reduce cancer recurrence in colorectal cancer patients with specific PI3K pathway mutations, according to findings presented at the ASCO Gastrointestinal Cancers Symposium.
